HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Axelson, M. Articles by Sjovall, J. Search for Related Content PubMed PubMed Citation Articles by Axelson, M. Articles by Sjovall, J. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol 36, 290-298, Copyright © 1995 by Lipid Research, Inc.

ARTICLES

Structural specificity in the suppression of HMG-CoA reductase in human fibroblasts by intermediates in bile acid biosynthesis

M Axelson, O Larsson, J Zhang, J Shoda and J Sjovall
Department of Clinical Chemistry, Karolinska Hospital, Stockholm, Sweden.

The effect of bile acid precursors on the activity of 3-hydroxy-3- methylglutaryl coenzyme A (HMG-CoA) reductase was investigated. Cholesterol and 34 of its derivatives, including 23 potential intermediates in bile acid biosynthesis, were incubated with cultures of human fibroblasts for 24 h in the absence or presence of lipoproteins, and the activity of HMG-CoA reductase was then determined. In the absence of lipoproteins, many of the bile acid intermediates were inhibitory at a high concentration (2.5 microM), while only three, 27-hydroxycholesterol, 7 alpha, 27-dihydroxy-4- cholesten-3-one, and 7 alpha, 12 alpha, 27-trihydroxy-4-cholesten-3- one, caused a significant suppression at lower concentrations (often > 80% suppression at 0.25 microM). Even at 0.06 microM these sterols caused > 50% suppression of the enzyme activity. In addition, 27- hydroxy-4-cholesten-3-one, not usually considered to be an intermediate in bile acid biosynthesis, was a very potent inhibitor. Comparative studies showed that the effect of the three bile acid precursors was similar to that of 25-hydroxy-, 24-hydroxy-, and 7-oxo-cholesterol and 3 beta-hydroxy-5 alpha-cholest-8(14)-en-15-one. The presence of lipoproteins decreased or eliminated the inhibitory effect of most intermediates. Studies of the metabolism of the three most potent inhibitors in the fibroblasts indicated that the suppression was due to the compounds per se and not to products of their metabolism. The results show that a few specific intermediates in the formation of bile acids are potent suppressors of HMG-CoA reductase.(ABSTRACT TRUNCATED AT 250 WORDS)
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. B. Reiss, N. W. Awadallah, S. Malhotra, M. C. Montesinos, E. S. L. Chan, N. B. Javitt, and B. N. Cronstein Immune complexes and IFN-{gamma} decrease cholesterol 27-hydroxylase in human arterial endothelium and macrophages J. Lipid Res., November 1, 2001; 42(11): 1913 - 1922. [Abstract] [Full Text] [PDF]

				E. Hall, P. Hylemon, Z. Vlahcevic, D. Mallonee, K. Valerie, N. Avadhani, and W. Pandak Overexpression of CYP27 in hepatic and extrahepatic cells: role in the regulation of cholesterol homeostasis Am J Physiol Gastrointest Liver Physiol, July 1, 2001; 281(1): G293 - G301. [Abstract] [Full Text] [PDF]

				G. J. Schroepfer Jr. Oxysterols: Modulators of Cholesterol Metabolism and Other Processes Physiol Rev, January 1, 2000; 80(1): 361 - 554. [Abstract] [Full Text] [PDF]

				R. S. Kushwaha, B. Guntupalli, E. M. Jackson, and H. C. McGill Jr Effect of Estrogen and Progesterone on the Expression of Hepatic and Extrahepatic Sterol 27-Hydroxylase in Baboons (Papio sp) Arterioscler. Thromb. Vasc. Biol., August 1, 1996; 16(8): 1088 - 1094. [Abstract] [Full Text]

				M. Axelson and O. Larsson 27-Hydroxylated Low Density Lipoprotein (LDL) Cholesterol Can Be Converted to 7alpha ,27-Dihydroxy-4-cholesten-3-one (Cytosterone) before Suppressing Cholesterol Production in Normal Human Fibroblasts. EVIDENCE THAT AN ALTERED METABOLISM OF LDL CHOLESTEROL CAN UNDERLIE A DEFECTIVE FEEDBACK CONTROL IN MALIGNANT CELLS J. Biol. Chem., May 31, 1996; 271(22): 12724 - 12736. [Abstract] [Full Text] [PDF]